Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Napoli, Campania, Italy, 80131 was renamed to Naples, Campania, Italy, 80131 and a Naples listing was added, with the page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T21:21:45.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T04:41:08.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This appears to be a version control update with no visible changes to study information or page layout.
    Difference
    0.0%
    Check dated 2026-02-14T13:14:56.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. This appears to be a minor technical update without changes to the study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-02-07T07:42:16.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated the page revision to v3.4.0. Capitalization and wording were updated for 'No FEAR Act Data' and 'Last Update Submitted that Met QC Criteria' (replacing the previous 'Last Update Submitted that met QC Criteria').
    Difference
    0.1%
    Check dated 2026-01-24T01:28:52.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T01:19:22.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.